{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:03:40Z","timestamp":1778569420083,"version":"3.51.4"},"reference-count":153,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1586\/erv.09.30","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T15:32:30Z","timestamp":1243870350000},"page":"729-745","source":"Crossref","is-referenced-by-count":22,"title":["Challenges and progress in the development of a serogroup B meningococcal vaccine"],"prefix":"10.1586","volume":"8","author":[{"given":"Susan","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Claire","family":"Hoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"CIT0001","unstructured":"WHO.Control of Epidemic Meningococcal Disease: WHO Practical Guidelines, 2nd Edition. World Health Organization, Geneva, Switzerland (1998)."},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2807\/esm.10.12.00586-en","volume":"10","author":"Trotter","year":"2005","journal-title":"Euro. Surveill."},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/clinids\/5.1.71","volume":"5","author":"Peltola","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.293.12.1433","volume":"293","author":"Mitka","year":"2005","journal-title":"JAMA"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.inf.0000154438.37306.ab","volume":"24","author":"Healy","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"CIT0009","first-page":"1100","volume":"57","year":"2008","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","volume":"126","author":"Wyle","year":"1972","journal-title":"J. Infect. Dis."},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/IAI.65.3.1045-1052.1997","volume":"65","author":"Devi","year":"1997","journal-title":"Infect. Immun."},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/IAI.65.3.1053-1060.1997","volume":"65","author":"Zollinger","year":"1997","journal-title":"Infect. Immun."},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/522190","volume":"45","author":"Howitz","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.137.5.1708","volume":"137","author":"Jennings","year":"1986","journal-title":"J. Immunol."},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1084\/jem.165.4.1207","volume":"165","author":"Jennings","year":"1987","journal-title":"J. Exp. Med."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0882-4010(89)90087-9","volume":"6","author":"Ashton","year":"1989","journal-title":"Microb. Pathog."},{"key":"CIT0019","unstructured":"Moe GR, Flitter BA. Protective anti-N-propionylNeisseria meningitidisgroup B polysaccharide monoclonal antibodies are reactive with non-capsular antigens expressed by group A, B, C and W135 strains. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2003.10.005","volume":"22","author":"Bruge","year":"2004","journal-title":"Vaccine"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect. Immun."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"CIT0024","unstructured":"WHO. Requirements for meningococcal polysaccharide vaccine. In:World Health Organisation Technical Report Series. No. 594. World Health Organization, Geneva, Switzerland (1976)."},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/CVI.00102-07","volume":"14","author":"Trotter","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/CVI.00341-07","volume":"14","author":"Welsch","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/IAI.71.4.1650-1655.2003","volume":"71","author":"Vermont","year":"2003","journal-title":"Infect. Immun."},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","volume":"13","author":"Martin","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/CVI.00195-07","volume":"14","author":"Findlow","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"key":"CIT0033","doi-asserted-by":"crossref","unstructured":"Frasch CE, Van Alphen L, Holst J, Poolman JT, Rosenqvist E. Outer membrane protein vesicle vaccines for meningococcal disease. In:Meningococcal vaccines. Pollard AJ, Maiden MC (Eds). Humana Press Inc., NJ, USA 81\u2013107 (2001).","DOI":"10.1385\/1-59259-148-5:81"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0092-1157(89)90017-6","volume":"17","author":"Tsai","year":"1989","journal-title":"J. Biol. Stand."},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/432102","volume":"192","author":"Hou","year":"2005","journal-title":"J. Infect. Dis."},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","volume":"64","author":"van der Voort","year":"1996","journal-title":"Infect. Immun."},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/IAI.66.7.3223-3231.1998","volume":"66","author":"Wedege","year":"1998","journal-title":"Infect. Immun."},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/00222615-43-5-335","volume":"43","author":"Idanpaan-Heikkila","year":"1995","journal-title":"J. Med. Microbiol."},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.59.9.2963-2971.1991","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect. Immun."},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.vaccine.2005.01.058","volume":"23","author":"Holst","year":"2005","journal-title":"Vaccine"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/CVI.00039-07","volume":"14","author":"Wedege","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0043","first-page":"125","volume":"14","author":"Bjune","year":"1991","journal-title":"NIPH Ann."},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/S0074-02761999000400002","volume":"94","author":"Rodriguez","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"CIT0045","first-page":"195","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann."},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00006454-200111000-00010","volume":"20","author":"Morley","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"CIT0047","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/24.5.1050","volume":"24","author":"Noronha","year":"1995","journal-title":"Int. J. Epidemiol."},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","volume":"177","author":"Perkins","year":"1998","journal-title":"J. Infect. Dis."},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect. Immun."},{"key":"CIT0051","volume":"7","author":"Holst","year":"2003","journal-title":"Eurosurveillance"},{"key":"CIT0052","unstructured":"Rosenqvist E, Bryn K, Harbak Ket al.Development of a tailor-made outer membrane vesicle vaccine against the group B meningococcal epidemic in New Zealand. Presented at:International Pathogenic Neisseria Conference. Oslo, Norway, 1\u20136 September 2002."},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.inf.0000258697.05341.2c","volume":"26","author":"Wong","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.vaccine.2005.09.043","volume":"24","author":"Thornton","year":"2006","journal-title":"Vaccine"},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2007.01.023","volume":"25","author":"Oster","year":"2007","journal-title":"Vaccine"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm147"},{"key":"CIT0057","author":"Galloway","year":"2008","journal-title":"Int. J. Epidemiol."},{"key":"CIT0058","unstructured":"Martin D, Lopez L. Has MeNZBTM controlled New Zealand\u2019s epidemic? Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0059","unstructured":"Martin D, Lopez L.The Epidemiology of Meningococcal Disease in New Zealand in 2007. Institute of Environmental Science and Research (2008)."},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37757\/MR2007V9.N1.6","volume":"9","author":"Sotolongo Padron","year":"2007","journal-title":"MEDICC Rev."},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.vaccine.2007.01.022","volume":"25","author":"Nokleby","year":"2007","journal-title":"Vaccine"},{"key":"CIT0062","first-page":"37","year":"2008","journal-title":"Wkly Epidemiol. Rec."},{"key":"CIT0063","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1472-8206.2007.00531.x","volume":"21","author":"Noblet","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"CIT0064","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.vaccine.2005.12.059","volume":"25","author":"Taha","year":"2007","journal-title":"Vaccine"},{"key":"CIT0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","volume":"137","author":"Gold","year":"1978","journal-title":"J. Infect. Dis."},{"key":"CIT0066","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0950268800066449","volume":"99","author":"Cartwright","year":"1987","journal-title":"Epidemiol. Infect."},{"key":"CIT0067","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect. Immun."},{"key":"CIT0068","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1128\/IAI.01062-06","volume":"74","author":"Li","year":"2006","journal-title":"Infect. Immun."},{"key":"CIT0069","unstructured":"Gorringe AR, Matheson M, Taylor Set al.Safety and immunogenicity of a meningococcal disease vaccine base onNeisseria lactamicain adult volunteers. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0070","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/IAI.66.4.1334-1341.1998","volume":"66","author":"Haneberg","year":"1998","journal-title":"Infect. Immun."},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect. Immun."},{"key":"CIT0072","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/IAI.62.7.2984-2990.1994","volume":"62","author":"Ala\u2019Aldeen","year":"1994","journal-title":"Infect. Immun."},{"key":"CIT0073","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1574-695X.1997.tb01085.x","volume":"19","author":"Johnson","year":"1997","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"CIT0074","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2958.1993.tb01657.x","volume":"8","author":"Irwin","year":"1993","journal-title":"Mol. Microbiol."},{"key":"CIT0075","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/jb.175.8.2448-2450.1993","volume":"175","author":"Cornelissen","year":"1993","journal-title":"J. Bacteriol."},{"key":"CIT0076","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0966-842X(96)10025-1","volume":"4","author":"Gray-Owen","year":"1996","journal-title":"Trends Microbiol."},{"key":"CIT0077","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0264-410X(93)90045-Y","volume":"11","author":"Danve","year":"1993","journal-title":"Vaccine"},{"key":"CIT0078","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/IAI.63.3.884-890.1995","volume":"63","author":"Lissolo","year":"1995","journal-title":"Infect. Immun."},{"key":"CIT0079","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1574-6968.1993.tb06294.x","volume":"110","author":"Rokbi","year":"1993","journal-title":"FEMS Microbiol. Lett."},{"key":"CIT0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/CDLI.4.5.522-529.1997","volume":"4","author":"Rokbi","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"CIT0081","unstructured":"Danve B, Lissolo L, Guinet Fet al.Safety and immunogenicity of aNeisseria meningitidisgroup B transferrin binding protein vaccine in adults. Presented at:11th International Pathogenic Neisseria Conference. Nice, France, 1\u20136 November 1998."},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2958.1993.tb00922.x","volume":"10","author":"Virji","year":"1993","journal-title":"Mol. Microbiol."},{"key":"CIT0083","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00293-06","volume":"74","author":"Callaghan","year":"2006","journal-title":"Infect. Immun."},{"key":"CIT0084","unstructured":"Callaghan MJ, Lewis S, Bailey SEet al.Evaluation of recombinant Opa proteins as vaccine candidates against hyperinvasive meningococci. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/IAI.64.1.298-304.1996","volume":"64","author":"Wiertz","year":"1996","journal-title":"Infect. Immun."},{"key":"CIT0086","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni769","volume":"3","author":"Boulton","year":"2002","journal-title":"Nat. Immunol."},{"key":"CIT0087","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1128\/IAI.00222-07","volume":"75","author":"Lee","year":"2007","journal-title":"Infect. Immun."},{"key":"CIT0088","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.185.7.1173","volume":"185","author":"Martin","year":"1997","journal-title":"J. Exp. Med."},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1128\/IAI.67.9.4955-4959.1999","volume":"67","author":"Cadieux","year":"1999","journal-title":"Infect. Immun."},{"key":"CIT0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-1656(00)00294-7","volume":"83","author":"Martin","year":"2000","journal-title":"J. Biotechnol."},{"key":"CIT0091","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.vaccine.2006.08.001","volume":"25","author":"Halperin","year":"2007","journal-title":"Vaccine"},{"key":"CIT0092","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/IAI.67.11.5664-5675.1999","volume":"67","author":"Moe","year":"1999","journal-title":"Infect. Immun."},{"key":"CIT0093","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1099\/00222615-41-4-236","volume":"41","author":"Scholten","year":"1994","journal-title":"J. Med. Microbiol."},{"key":"CIT0094","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2008.09.041","volume":"26","author":"Jakel","year":"2008","journal-title":"Vaccine"},{"key":"CIT0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/infdis\/150.1.71","volume":"150","author":"Griffiss","year":"1984","journal-title":"J. Infect. Dis."},{"key":"CIT0096","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-1759(00)00142-3","volume":"237","author":"Plested","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"CIT0097","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0264-410X(99)00216-9","volume":"18","author":"Drabick","year":"1999","journal-title":"Vaccine"},{"key":"CIT0098","unstructured":"Poolman JT. Polysaccharides and membrane vaccines. In:Bacterial Vaccines. Mizrahi A (Ed.). John Wiley and Sons Ltd, New York, USA, 57\u201386 (1990)."},{"key":"CIT0099","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1128\/IAI.59.10.3604-3609.1991","volume":"59","author":"Tsai","year":"1991","journal-title":"Infect. Immun."},{"key":"CIT0100","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1099\/00221287-145-11-3013","volume":"145","author":"Jennings","year":"1999","journal-title":"Microbiology"},{"key":"CIT0101","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/09680519030090020901","volume":"9","author":"van der Ley","year":"2003","journal-title":"J. Endotoxin Res."},{"key":"CIT0102","unstructured":"Zollinger WD, Moran EE, Ray J, McClain B. Phase I safety and immunogenicity study of a meningococcal outer membrane protein, detoxified LPS vaccine. Presented at:Frontiers in Vaccine Research. Hanasaari, Finland, 9\u201311 September 1991."},{"key":"CIT0103","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/IAI.69.5.3203-3213.2001","volume":"69","author":"Plested","year":"2001","journal-title":"Infect. Immun."},{"key":"CIT0104","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1128\/IAI.67.10.5417-5426.1999","volume":"67","author":"Plested","year":"1999","journal-title":"Infect. Immun."},{"key":"CIT0105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/368360","volume":"187","author":"Plested","year":"2003","journal-title":"J. Infect. Dis."},{"key":"CIT0106","unstructured":"Pavliak V, Fortuna-Nevin M, Monteiro M, Mason K, Zhu D.Neisseria meningitidisLOS conjugate vaccine against meningococcal disease. Presented at:14th International Pathogenic Neisseria Conference. Milwaukee, WI, USA, 5\u201310 September 2004."},{"key":"CIT0107","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine"},{"key":"CIT0108","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"CIT0109","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","volume":"195","author":"Comanducci","year":"2002","journal-title":"J. Exp. Med."},{"key":"CIT0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/CVI.00252-07","volume":"15","author":"Norheim","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0111","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1128\/IAI.72.7.4052-4060.2004","volume":"72","author":"Bowe","year":"2004","journal-title":"Infect. Immun."},{"key":"CIT0112","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.vaccine.2008.05.049","volume":"26","author":"Ciabattini","year":"2008","journal-title":"Vaccine"},{"key":"CIT0113","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1086\/514821","volume":"195","author":"Beernink","year":"2007","journal-title":"J. Infect. Dis."},{"key":"CIT0114","unstructured":"Lucidarme J, Comanducci M, Findlow Jet al.The presence and genetic diversity of three meningococcal vaccine candidate genes,nadA, fHbpandgna2132, in ST-269 clonal complex isolates in England and Wales. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0115","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.137.8.2676","volume":"137","author":"Lex","year":"1986","journal-title":"J. Immunol."},{"key":"CIT0116","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect. Immun."},{"key":"CIT0117","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","volume":"197","author":"Masignani","year":"2003","journal-title":"J. Exp. Med."},{"key":"CIT0118","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.vaccine.2006.03.051","volume":"24","author":"Zhu","year":"2006","journal-title":"Vaccine"},{"key":"CIT0119","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1128\/IAI.73.10.6838-6845.2005","volume":"73","author":"Zhu","year":"2005","journal-title":"Infect. Immun."},{"key":"CIT0120","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.vaccine.2005.01.056","volume":"23","author":"Pillai","year":"2005","journal-title":"Vaccine"},{"key":"CIT0121","unstructured":"Murphy E, Andrew L, Lee KLet al.Sequence diversity of vaccine candidate LP2086 inNeisseria meningitidisserogroup B strains causing invasive disease. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0122","unstructured":"Jiang HQ, Harris SL, Tan Cet al.Prediction of broad vaccine coverage for a bivalent rLP2086 based vaccine which elicits serum bactericidal activity against a diverse collection of serogroup B Meningococci. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0123","unstructured":"Anderson AS, Xu R, Tan Cet al.Functional cross-reactive antibodies are elicited by a Group BNeisseria meningitidisbivalent recombinant lipidated LP2086 vaccine in Cynomolgus macaques. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0124","unstructured":"Nissen MD, Marshall HS, Richmond Pet al.A randomised, placebo-controlled, double-blind, Phase I trial of ascending doses of meningococcal group B rLP2086 vaccine. Presented at:26th Annual Meeting of the European Society for Paediatric Infectious Diseases. Graz, Austria, 13\u201317 May 2008."},{"key":"CIT0125","unstructured":"Richmond P, Marshall HS, Nissen MDet al.A randomized, observed-blinded, active control, Phase 1 trial of meningococcal serogroup B rLP2086 vaccine in healthy children and adolescent aged 8 to 14 years. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0126","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","volume":"172","author":"Welsch","year":"2004","journal-title":"J. Immunol."},{"key":"CIT0127","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","volume":"197","author":"Welsch","year":"2008","journal-title":"J. Infect. Dis."},{"key":"CIT0128","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.01071-08","volume":"77","author":"Seib","year":"2009","journal-title":"Infect. Immun."},{"key":"CIT0129","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"CIT0130","unstructured":"Snape MD, Dawson T, Morant Aet al.immungenicity and reactogenicity of a novel serogroup BNeisseria meningitidisvaccine administered from 6 months of age. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0131","unstructured":"Miller E, Pollard AJ, Borrow Ret al.Safety and immunogenicity of Novartis meningoccocal serogroup B vaccine (MenB vaccine) after three doses adminstered in infancy. Presented at:26th Annual Meeting of the European Society for Paediatric Infectious Diseases. Graz, Austria, 13\u201317 May 2008."},{"key":"CIT0132","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","volume":"188","author":"Welsch","year":"2003","journal-title":"J. Infect. Dis."},{"key":"CIT0133","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(00)00320-0","author":"de Kleijn","year":"2000","journal-title":"Vaccine"},{"key":"CIT0134","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"key":"CIT0135","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.vaccine.2006.09.025","volume":"25","author":"van den Dobbelsteen","year":"2007","journal-title":"Vaccine"},{"key":"CIT0136","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0882-4010(88)90045-9","volume":"4","author":"Abdillahi","year":"1988","journal-title":"Microb. Pathog."},{"key":"CIT0137","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.38.9.3323-3328.2000","volume":"38","author":"Tondella","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"CIT0138","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0264-410X(95)98264-B","volume":"13","author":"van der Ley","year":"1995","journal-title":"Vaccine"},{"key":"CIT0139","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"key":"CIT0140","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1128\/IAI.71.11.6367-6371.2003","volume":"71","author":"Luijkx","year":"2003","journal-title":"Infect. Immun."},{"key":"CIT0141","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0264-410X(99)00423-5","volume":"18","author":"de Kleijn","year":"2000","journal-title":"Vaccine"},{"key":"CIT0142","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.vaccine.2005.10.003","volume":"24","author":"Luijkx","year":"2006","journal-title":"Vaccine"},{"key":"CIT0143","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CVI.00230-06","volume":"14","author":"Boutriau","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0144","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/CVI.00094-07","volume":"14","author":"Sandbu","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0145","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/IAI.00411-07","volume":"75","author":"Weynants","year":"2007","journal-title":"Infect. Immun."},{"key":"CIT0146","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","volume":"67","author":"Saunders","year":"1999","journal-title":"Infect. Immun."},{"key":"CIT0147","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.70.2.702-707.2002","volume":"70","author":"Katial","year":"2002","journal-title":"Infect. Immun."},{"key":"CIT0148","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/IAI.73.7.4070-4080.2005","volume":"73","author":"Fisseha","year":"2005","journal-title":"Infect. Immun."},{"key":"CIT0149","unstructured":"Keiser PB, Moran EE, Schmeil DHet al.A Phase 1 study of the safety and immunogenicity of an intramuscular group B meningococcal NOMV vaccine made from an lpxL2 and synX deleted strain. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0150","unstructured":"Donets M, Fisseha M, Kijek Tet al.Genetic modifications of three meningococcal group B multivalent vaccine strains. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0151","unstructured":"Labrie JE, Donets M, Ionin Bet al.Immunogenicity of a native outer membrane vesicle vaccine forNeisseria meningitidisserogroup B in rabbits. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0152","unstructured":"Pinto VB, Moran E, Schmiel Det al.Analysis of the immune response to an investigational three componenetN. menigitidisNOMV vaccine in mice. Presented at:International Pathogenic Neisseria Conference. Rotterdam, The Netherlands, 7\u201312 September 2008."},{"key":"CIT0153","unstructured":"EU\u2013IBIS.InvasiveNeisseria meningitidisin Europe 2006. Health Protection Agency, London, UK 2006."}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/erv.09.30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T12:15:50Z","timestamp":1685016950000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/erv.09.30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":153,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,1,9]]},"published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1586\/erv.09.30"],"URL":"https:\/\/doi.org\/10.1586\/erv.09.30","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}